NR4A2 and idiopathic dilated cardiomyopathy: To further investigate the pathophysiological relevance of these findings, cardiac NR4A2 mRNA levels were quantified in patients diagnosed with end-stage idiopathic dilated cardiomyopathy, both at time of implantation and explantation of a left ventricular assist device (LVAD).